VM206RY

· Reyon Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VM206RY, covering 2015-01-21 to 2015-01-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of VM206RY in Subjects With Expression of HER2 in Breast Cancer [Phase 1]